September 3-8, 2023
The upcoming MaNaPro/ECMNP Conference in Granada, Spain, is set to be an exciting gathering of experts in the field of marine natural product research. Among the numerous sessions and discussions planned for the event, one particular highlight is the policy session organised by our BlueRemediomics partners at the University of Aberdeen.
This 75-minute panel discussion, scheduled for Monday, September 4th, aims to shed light on the new policy instruments that will significantly impact marine natural product research. Specifically, the session will delve into the BBNJ treaty and the DSI decision at the CBD, two critical UN treaties that will shape the future of this field.
The policy session, led by University of Aberdeen, seeks to provide conference attendees with valuable insights into the latest policy developments and their implications for marine natural product research. The panel discussion will feature experts who possess a deep understanding of the BBNJ treaty and the DSI decision at the CBD.
The BBNJ Treaty:
The BBNJ treaty is the new legally binding international instrument on the conservation and sustainable use of marine biological diversity in areas beyond national jurisdiction. It was adopted on 19 June, at the United Nations headquarters in New York, United States.
The DSI Decision at the CBD:
The DSI decision, referring to “Digital Sequence Information on Genetic Resources,” is a critical policy decision made under the Convention on Biological Diversity (CBD). It addresses the access and benefit-sharing framework for genetic resources, including marine organisms, that are used for research and development. The decision holds significant implications for marine natural product research, particularly regarding the sharing of data and the fair and equitable distribution of benefits.